Ruyuan He
- Infectious Diseases top 5%
- Neurology top 10%
-
- interferon and immune responses 3
- Immune cells in cancer 3
-
- Ferroptosis and cancer prognosis 4
- Lung Cancer Diagnosis and Treatment 3
-
- Inflammasome and immune disorders 5
- Heme Oxygenase-1 and Carbon Monoxide 3
-
- Autophagy in Disease and Therapy 3
-
- COVID-19 diagnosis using AI 3
- Journals
- Life Sciences (1 paper)Ecotoxicology and Environmental Safety (1 paper)Frontiers in Pharmacology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Ruyuan He
28 papers receiving 989 citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Infectious Diseases 293
- Neurology 151
- Cancer Research 147
- Immunology 180
- Pulmonary and Respiratory Medicine 240
Countries citing papers authored by Ruyuan He
This map shows the geographic impact of Ruyuan He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruyuan He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruyuan He more than expected).
Fields of papers citing papers by Ruyuan He
This network shows the impact of papers produced by Ruyuan He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruyuan He. The network helps show where Ruyuan He may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ruyuan He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 14 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 39 | |
| 10 | 2023 | 36 | |
| 11 | 2022 | 18 | |
| 12 | 2022 | 2 | |
| 13 | 2021 | 43 | |
| 14 | 2021 | 26 | |
| 15 | 2021 | 60 | |
| 16 | 2021 | 74 | |
| 17 | 2020 | 170 | |
| 18 | 2020 | 182 | |
| 19 | 2020 | 44 | |
| 20 | 2020 | 6 |
About Ruyuan He
Ruyuan He is a scholar working on Pulmonary and Respiratory Medicine, Complementary and alternative medicine and Immunology, having authored 29 papers that have together received 995 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (5 papers), Ferroptosis and cancer prognosis (4 papers), interferon and immune responses (3 papers), Autophagy in Disease and Therapy (3 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers), Immune cells in cancer (3 papers), Lung Cancer Diagnosis and Treatment (3 papers) and COVID-19 diagnosis using AI (3 papers). The work is most often cited by research in Infectious Diseases (293 citations), Neurology (151 citations) and Cancer Research (147 citations). Ruyuan He has collaborated with scholars based in China and United States. Frequent co-authors include Qing Geng, Wenyang Jiang, Bohao Liu, Weichen Lin, Heng Meng, Ning Li, Bo Hao, Zilong Lu, Rui Xiong and Tao Fan. Their work appears in journals such as Life Sciences, Ecotoxicology and Environmental Safety and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.